ACOR - アコ―ダ・セラピュ―ティクス (Acorda Therapeutics Inc.)


   Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q1 2018 Results - Earnings Call Transcript  2019-05-02
Acorda Therapeutics (ACOR) Q1 2018 Results Earnings Conference Call May 02, 2019, 08:30 AM ET Company Participants Felicia Vonella - Executive Director, IR Ron Cohen - CEO Lauren Sabella - CCO David Lawrence - CTO, Chief of Business Operations & Principal Accounting Officer…
   Acorda First Quarter 2019 Update: Webcast/Conference Call Scheduled for May 2, 2019  2019-04-18 Business Wire
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast to report its first quarter 2019 update and financial results onThursday, May 2 at 8:30 a.m. ET. To participate in the conference call, please dial (866) 393-4306 (domestic) or (734) 385-2616 (internat…